SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001415889-15-002433
Filing Date
2015-07-21
Accepted
2015-07-21 17:15:04
Documents
15

Document Format Files

Seq Description Document Type Size
1 S-1 vstas1_jul212015.htm S-1 4090959
2 CONSENT OF OUM & CO. LLP ex23-2.htm EX-23.2 3557
3 av101image.jpg GRAPHIC 76677
4 figure-1.jpg GRAPHIC 61735
5 image7cikyna.jpg GRAPHIC 47603
6 figure3.jpg GRAPHIC 28761
7 figure4.jpg GRAPHIC 28541
8 figure5.jpg GRAPHIC 27388
9 figure6.jpg GRAPHIC 27671
  Complete submission text file 0001415889-15-002433.txt   10428897

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT vsta-20150331.xml EX-101.INS 1837258
11 XBRL TAXONOMY EXTENSION SCHEMA vsta-20150331.xsd EX-101.SCH 80859
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vsta-20150331_cal.xml EX-101.CAL 56361
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vsta-20150331_def.xml EX-101.DEF 184430
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE vsta-20150331_lab.xml EX-101.LAB 394352
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vsta-20150331_pre.xml EX-101.PRE 334777
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-244-9990
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: S-1 | Act: 33 | File No.: 333-205782 | Film No.: 15998422
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences